Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets

被引:24
|
作者
Falker, Knut [1 ]
Haglund, Linda [2 ]
Gunnarsson, Peter [2 ]
Nylander, Martina [1 ]
Lindahl, Tomas L. [1 ]
Grenegard, Magnus [2 ]
机构
[1] Linkoping Univ, Fac Med, Div Clin Chem, Dept Clin & Expt Med,Univ Hosp, S-58185 Linkoping, Sweden
[2] Linkoping Univ, Fac Med, Div Drug Res Pharmacol, Dept Med & Hlth Sci,Univ Hosp, S-58185 Linkoping, Sweden
关键词
ADP; desensitization; P2Y(12) receptor; platelet; protease-activated receptor (PAR); protein kinase C (PKC); KINASE-C-BETA; THROMBIN RECEPTOR; SHAPE CHANGE; PATHWAYS; ADP; PHOSPHORYLATION; SPECIFICITY; INHIBITION; PROTEINS; CLEAVAGE;
D O I
10.1042/BJ20101360
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FARs (protease-activated receptors) 1 and 4 belong to the family of G-protein-coupled receptors which induce both G(alpha 12/13) and G(alpha q) signalling. By applying the specific PAR1- and PAR4-activating hexapeptides, SFLLRN and AYPGKF respectively, we found that aggregation of isolated human platelets mediated via PAR1, but not via PAR4, is abolished upon homologous receptor activation in a concentration- and time-dependent fashion. This effect was not due to receptor internalization, but to a decrease in Ca(2+) mobilization, PKC (protein kinase C) signalling and alpha-granule secretion, as well as to a complete lack of dense granule secretion. Interestingly, subthreshold PAR4 activation rapidly abrogated PAR1 signalling desensitization by differentially reconstituting these affected signalling events and functional responses, which was sufficient to re-establish aggregation. The lack of ADP release and P2Y(12) receptor-induced G(alpha i) signalling accounted for the loss of the aggregation response, as mimicking G(alpha i/z) signalling with 2-MeS-ADP (2-methylthioadenosine-5'-O-diphosphate) or epinephrine (adrenaline) could substitute for intermediate PAR4 activation. Finally, we found that the re-sensitization of PAR1 signalling-induced aggregation via PAR4 relied on PKC-mediated release of both ADP from dense granules and fibrinogen from alpha-granules. The present study elucidates further differences in human platelet PAR signalling regulation and provides evidence for a cross-talk in which PAR4 signalling counteracts mechanisms involved in PAR1 signalling down-regulation.
引用
收藏
页码:469 / 480
页数:12
相关论文
共 50 条
  • [41] Osteogenesis in human periodontal ligament stem cell sheets is enhanced by the protease-activated receptor 1 (PAR1) in vivo
    Tomaz Alves
    Letícia M. Gasparoni
    Danilo Balzarini
    Emmanuel Albuquerque-Souza
    Victhor de Oliveira
    Emanuel S. Rovai
    Jose da Silva
    Aldrin Huamán-Mendoza
    Luiz H. Catalani
    Carla R. Sipert
    Marinella Holzhausen
    Scientific Reports, 12
  • [42] Protease-activated receptor 1 (PAR1) inhibits synaptic NMDARs in mouse nigral dopaminergic neurons
    Price, Rachel
    Ferrari, Elena
    Gardoni, Fabrizio
    Mercuri, Nicola Biagio
    Ledonne, Ada
    PHARMACOLOGICAL RESEARCH, 2020, 160
  • [43] Developmental Role of Zebrafish Protease-Activated Receptor 1 (PAR1) in the Cardio-Vascular System
    Ellertsdottir, Elin
    Berthold, Peter R.
    Bouzaffour, Mohamed
    Dufourcq, Pascale
    Trayer, Vincent
    Gauron, Carole
    Vriz, Sophie
    Affolter, Markus
    Rampon, Christine
    PLOS ONE, 2012, 7 (07):
  • [44] Osteogenesis in human periodontal ligament stem cell sheets is enhanced by the protease-activated receptor 1 (PAR1) in vivo
    Alves, Tomaz
    Gasparoni, Leticia M.
    Balzarini, Danilo
    Albuquerque-Souza, Emmanuel
    de Oliveira, Victhor
    Rovai, Emanuel S.
    da Silva, Jose
    Huaman-Mendoza, Aldrin
    Catalani, Luiz H.
    Sipert, Carla R.
    Holzhausen, Marinella
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [45] Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
    Friebel, Julian
    Moritz, Eileen
    Witkowski, Marco
    Jakobs, Kai
    Straessler, Elisabeth
    Doerner, Andrea
    Steffens, Daniel
    Puccini, Marianna
    Lammel, Stella
    Glauben, Rainer
    Nowak, Franziska
    Kraenkel, Nicolle
    Haghikia, Arash
    Moos, Verena
    Schutheiss, Heinz-Peter
    Felix, Stephan B.
    Landmesser, Ulf
    Rauch, Bernhard H.
    Rauch, Ursula
    CELLS, 2021, 10 (12)
  • [46] Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)
    Das, Mitali
    Ithychanda, Sujay Subbayya
    Plow, Edward F.
    BIOMOLECULES, 2022, 12 (02)
  • [47] Discovery of Potent Orally Active Protease-Activated Receptor 1 (PAR1) Antagonists Based on Andrographolide
    Liu, Jun
    Sun, Bin
    Zhao, Xiaoyu
    Xing, Jie
    Gao, Yanhui
    Chang, Wenqiang
    Ji, Jianbo
    Zheng, Hongbo
    Cui, Changyi
    Ji, Aiguo
    Lou, Hongxiang
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (16) : 7166 - 7185
  • [48] Protease-Activated Receptor 1 (PAR1) Deficiency is Associated with Reduced Bone Mass and Density in Mice
    Larson, Hillary
    Klein, Robert
    Grover, Steven
    Mackman, Nigel
    Larson, Emily
    Taylor, Jason
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 267 - 267
  • [49] Cockroach Allergen Proteinases Regulate Proteinase-Activated Receptor-1 (PAR1) Signalling
    Polley, Danny
    Mihara, Koichiro
    Ramachandran, Rithwik
    Vliagoftis, Harissios
    Boitano, Scott
    Hollenberg, Morley D.
    Daines, Michael
    FASEB JOURNAL, 2013, 27
  • [50] Exploring protease signalling within the cell, a focus on mitochondrial PAR4
    Bonfanti, Marco
    Qu, Tianshu
    Gould, Gwyn
    Cunningham, Margaret Rose
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 669 - 670